Last reviewed · How we verify
NCT07208292: RWS-GU001
Real-world Study on Preoperative Application of Rezvilutamide
trial in Preoperative Evaluation in 115 participants. Not yet recruiting.
15 July 2026
Quick facts
| Lead sponsor | Shanghai Pudong New Area Gongli Hospital |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 115 |
| Start date | 15 October 2025 |
| Primary completion | 15 July 2026 |
| Estimated completion | 15 July 2027 |
Conditions studied
- Preoperative Evaluation — all drugs for Preoperative Evaluation →
Sponsor
Shanghai Pudong New Area Gongli Hospital
Who can join
18 and older, male only, with Preoperative Evaluation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Real-world study on Preoperative Application of Rezvilutamide
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07208292
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preoperative Evaluation
Currently open trials in the same condition.
- NCT07459491 — Agreement Between ChatGPT-5 and Anesthesiologists in Preoperative Risk Assessment: ASA Classification · active not recruiting
- NCT06779682 — Systematic Screening for Obstructive Sleep Apnea During Preoperative Consultation Using AI-preoperative Agents · active not recruiting
Other Shanghai Pudong New Area Gongli Hospital trials
Trials by the same sponsor.
- NCT03076450 — Evaluation of POC Lung Ultrasound Combined With Pressure-volume Curve to Titration Adjust PEEP for ARDS Lung Recruitment · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07208292 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shanghai Pudong New Area Gongli Hospital
- Last refreshed: 6 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07208292.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing